Litcius/Paper detail

Discovery and intranasal administration of a SARS-CoV-2 broadly acting neutralizing antibody with activity against multiple Omicron subvariants

J. Andrew Duty, Thomas Kraus, Heyue Zhou, Yanliang Zhang, Namir Shaabani, Soner Yildiz, Na Du, Alok Singh, Lisa Miorin, Donghui Li, Karen Stegman, Sabrina I. Ophir, Xia Cao, Kristina Atanasoff, Reyna K. V. Lim, Ignacio Mena, Nicole M. Bouvier, Shreyas Kowdle, Juan Manuel Carreño, Laura Rivero-Nava, Ariel Raskin, Elena Moreno, Sachi Johnson, Raveen Rathnasinghe, Chin I Pai, Thomas Kehrer, Elizabeth Paz Cabral, Sonia Jangra, Laura Healy, Gagandeep Singh, Prajakta Warang, Viviana Simon, Emilia Mia Sordillo, Harm van Bakel, Yonghong Liu, Weina Sun, Lisa Kerwin, John R. Teijaro, Michael Schotsaert, Florian Krammer, Damien Bresson, Adolfo García‐Sastre, Yanwen Fu, Benhur Lee, Colin Powers, Thomas M. Moran, Henry Ji, Domenico Tortorella, Robert Allen

2022Med23 citationsDOIOpen Access PDF

Topics & Concepts

NeutralizationAntibodyNeutralizing antibodyNasal administrationVirologyTiterPotencyVirusMedicineImmunologyBiologyIn vitroGeneticsSARS-CoV-2 and COVID-19 Researchvaccines and immunoinformatics approachesCOVID-19 Clinical Research Studies
Discovery and intranasal administration of a SARS-CoV-2 broadly acting neutralizing antibody with activity against multiple Omicron subvariants | Litcius